3301 related articles for article (PubMed ID: 18396365)
1. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
Gamble JF; Gibbs GW
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
[TBL] [Abstract][Full Text] [Related]
2. Mesothelioma and asbestos.
Gibbs GW; Berry G
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S223-31. PubMed ID: 18022298
[TBL] [Abstract][Full Text] [Related]
3. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
[TBL] [Abstract][Full Text] [Related]
5. Differentiating non-asbestiform amphibole and amphibole asbestos by size characteristics.
Harper M; Lee EG; Doorn SS; Hammond O
J Occup Environ Hyg; 2008 Dec; 5(12):761-70. PubMed ID: 18828048
[TBL] [Abstract][Full Text] [Related]
6. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
Hodgson JT; Darnton A
Ann Occup Hyg; 2000 Dec; 44(8):565-601. PubMed ID: 11108782
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment due to environmental exposures to fibrous particulates associated with taconite ore.
Wilson R; McConnell EE; Ross M; Axten CW; Nolan RP
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S232-45. PubMed ID: 18207296
[TBL] [Abstract][Full Text] [Related]
8. An overview of the risk of lung cancer in relation to exposure to asbestos and of taconite miners.
Berry G; Gibbs GW
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S218-22. PubMed ID: 17998152
[TBL] [Abstract][Full Text] [Related]
9. Tremolite and mesothelioma.
Roggli VL; Vollmer RT; Butnor KJ; Sporn TA
Ann Occup Hyg; 2002 Jul; 46(5):447-53. PubMed ID: 12176759
[TBL] [Abstract][Full Text] [Related]
10. Case-referent survey of young adults with mesothelioma: I. Lung fibre analyses.
McDonald JC; Armstrong BG; Edwards CW; Gibbs AR; Lloyd HM; Pooley FD; Ross DJ; Rudd RM
Ann Occup Hyg; 2001 Oct; 45(7):513-8. PubMed ID: 11583653
[TBL] [Abstract][Full Text] [Related]
11. An inter-laboratory study to determine the effectiveness of procedures for discriminating amphibole asbestos fibers from amphibole cleavage fragments in fiber counting by phase-contrast microscopy.
Harper M; Lee EG; Slaven JE; Bartley DL
Ann Occup Hyg; 2012 Jul; 56(6):645-59. PubMed ID: 22456032
[TBL] [Abstract][Full Text] [Related]
12. Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec.
Dufresne A; Harrigan M; Massé S; Bégin R
Am J Ind Med; 1995 Apr; 27(4):581-92. PubMed ID: 7793429
[TBL] [Abstract][Full Text] [Related]
13. Industrial-grade talc exposure and the risk of mesothelioma.
Price B
Crit Rev Toxicol; 2010 Jul; 40(6):513-30. PubMed ID: 20230253
[TBL] [Abstract][Full Text] [Related]
14. Environmental mesothelioma associated with tremolite asbestos: lessons from the experiences of Turkey, Greece, Corsica, New Caledonia and Cyprus.
Constantopoulos SH
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S110-5. PubMed ID: 18171598
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.
Pierce JS; McKinley MA; Paustenbach DJ; Finley BL
Crit Rev Toxicol; 2008; 38(3):191-214. PubMed ID: 18324516
[TBL] [Abstract][Full Text] [Related]
16. Airborne fibre concentrations and lung burden compared to the tumour response in rats and humans exposed to asbestos.
Rödelsperger K; Woitowitz HJ
Ann Occup Hyg; 1995 Oct; 39(5):715-25. PubMed ID: 8526402
[TBL] [Abstract][Full Text] [Related]
17. Measuring EMPs in the lung what can be measured in the lung: Asbestiform minerals and cleavage fragments.
Roggli VL
Toxicol Appl Pharmacol; 2018 Dec; 361():14-17. PubMed ID: 29959999
[TBL] [Abstract][Full Text] [Related]
18. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.
Garabrant DH; Pastula ST
Toxicol Appl Pharmacol; 2018 Dec; 361():127-136. PubMed ID: 30077661
[TBL] [Abstract][Full Text] [Related]
19. Mesothelioma associated with environmental exposures.
Pasetto R; Comba P; Marconi A
Med Lav; 2005; 96(4):330-7. PubMed ID: 16457429
[TBL] [Abstract][Full Text] [Related]
20. Asbestos-related disease associated with exposure to asbestiform tremolite.
Srebro SH; Roggli VL
Am J Ind Med; 1994 Dec; 26(6):809-19. PubMed ID: 7892832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
